2023 China E-cigarette Exports Surge to $11.08 billion Amid 21.55% Unit Price Decline

Industry Insight by 2FIRSTS, edited by Sophia
Jan.26.2024
2023 China E-cigarette Exports Surge to $11.08 billion Amid 21.55% Unit Price Decline
China's e-cigarette exports saw significant growth in 2023, reaching $11.08 billion, an increase of 12.48% compared to the previous year.

As the Chinese customs released the e-cigarette export data for December, 2FIRSTS has compiled the data for the period of January to December 2023. The export scale of e-cigarettes from China in 2023 has once again witnessed a significant growth, reaching a total of $11.08 billion, representing a year-on-year increase of 12.48%.

 

Total export volume amounted to 233,000 tons, representing a YoY increase of 43.37%.

 

In 2023, China's total e-cigarette exports reached 233,000 tons, representing a staggering growth rate of 43.37% compared to 162,800 tons in 2022.

 

The average export unit price has decreased by 21.55%.

 

However, it is worth noting that despite the strong growth in both the total export value and quantity, the average export unit price of Chinese e-cigarettes in 2023 has declined by 21.55%, dropping from $60.54 per kilogram in 2022 to $47.50 per kilogram.

 

This may reflect the sensitivity of the international market to the prices of e-cigarette products and the price competition strategy adopted by manufacturers to capture market share.

 

Covering 167 countries and regions worldwide, with 10 new destinations added.

 

In 2023, the market coverage of Chinese e-cigarettes has further expanded, with exports reaching a total of 167 countries and regions worldwide, an increase of 10 from the previous year.

 

New destinations that have been added include Afghanistan, Benin, Burkina Faso, Equatorial Guinea, French Saint Martin, Fiji, Democratic Republic of Congo, Cuba, Guam, Dutch Saint Maarten, Canary Islands, Gabon, Malawi, Marshall Islands, Mauritania, American Samoa, Federated States of Micronesia, South Sudan, Nicaragua, Samoa, Turkmenistan, Wallis and Futuna, Uganda, and Taiwan, China, among other countries and regions.

 

Exports have been reduced to 14 countries and regions.

 

In 2023, the export of e-cigarettes to 14 countries and regions, including Botswana, the Republic of Congo, Kiribati, Guinea-Bissau, the Cook Islands, Liberia, Martinique, Mauritius, Monaco, Niger, Palau, Seychelles, Saint Lucia, and Brunei, has also been suspended.

 

The export scale of Chinese e-cigarettes continued to experience robust growth in 2023, leading to continuous adjustments in the market landscape. However, the decrease in prices may potentially trigger profound thinking and strategic adjustments within the industry.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
At InterTabac 2026, nicotine pouch growth was visible not only in brands but across equipment, raw materials and OEM manufacturing. 2Firsts interviewed AIRSCREAM commercial head Steve Moore on how many pouch factories Europe may ultimately need and where manufacturers can differentiate, from formulation and flavour to pouch materials, production consistency and customer service. The category continues to expand, but questions remain over future capacity, consolidation and the long-term structure of the supply chain.
Sep.18
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09